113 related articles for article (PubMed ID: 31520191)
1. A Non-innocent Magnesium Organoclay-Based Drug Vehicle for Improving the Cancer Therapy Effect of Methotrexate.
Li J; Qiao S; Tan G; Yu Y; Liu D; Pan W
AAPS PharmSciTech; 2019 Sep; 20(8):309. PubMed ID: 31520191
[TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma.
Ruckmani K; Sivakumar M; Ganeshkumar PA
J Nanosci Nanotechnol; 2006; 6(9-10):2991-5. PubMed ID: 17048509
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
5. In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma.
Ray S; Saha S; Sa B; Chakraborty J
Drug Deliv Transl Res; 2017 Apr; 7(2):259-275. PubMed ID: 28050892
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
[TBL] [Abstract][Full Text] [Related]
7. A novel method to prepare magnetite chitosan microspheres conjugated with methotrexate (MTX) for the controlled release of MTX as a magnetic targeting drug delivery system.
Zhang X; Chen F; Ni J
Drug Deliv; 2009 Jul; 16(5):280-8. PubMed ID: 19538010
[TBL] [Abstract][Full Text] [Related]
8. Anionic clay as the drug delivery vehicle: tumor targeting function of layered double hydroxide-methotrexate nanohybrid in C33A orthotopic cervical cancer model.
Choi G; Piao H; Alothman ZA; Vinu A; Yun CO; Choy JH
Int J Nanomedicine; 2016; 11():337-48. PubMed ID: 26855572
[TBL] [Abstract][Full Text] [Related]
9. [Intratumoral administration of methotrexate bound to activated carbon particles (MTX-CH) inducing antitumor effect in vivo].
Nakase Y; Kin S; Fukuda K; Takagi T; Shimomura K; Ito T; Sakakura C; Otsuji E; Ueda Y; Sonoyama T; Itoi H; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1859-61. PubMed ID: 14619539
[TBL] [Abstract][Full Text] [Related]
10. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system.
Yousefi G; Foroutan SM; Zarghi A; Shafaati A
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):147-53. PubMed ID: 20118571
[TBL] [Abstract][Full Text] [Related]
12. Local administration of methotrexate bound to activated carbon particles (MTX-CH) for treating cancers in mice.
Ito T; Hagiwara A; Takagi T; Fujiyama J; Sonoyama Y; Shimomura K; Takemura M; Toma A; Kin S; Nakase Y; Yamagishi H
Anticancer Res; 2003; 23(2B):1401-4. PubMed ID: 12820401
[TBL] [Abstract][Full Text] [Related]
13. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor efficacy by methotrexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancer.
Chen Y; Zhang W; Gu J; Ren Q; Fan Z; Zhong W; Fang X; Sha X
Int J Pharm; 2013 Aug; 452(1-2):421-33. PubMed ID: 23688623
[TBL] [Abstract][Full Text] [Related]
15. Fullerenol-Based Intracellular Delivery of Methotrexate: A Water-Soluble Nanoconjugate for Enhanced Cytotoxicity and Improved Pharmacokinetics.
Bahuguna S; Kumar M; Sharma G; Kumar R; Singh B; Raza K
AAPS PharmSciTech; 2018 Apr; 19(3):1084-1092. PubMed ID: 29159749
[TBL] [Abstract][Full Text] [Related]
16. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.
Ferreira M; Chaves LL; Lima SA; Reis S
Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145
[TBL] [Abstract][Full Text] [Related]
17. Controlled release of methotrexate from w/o microemulsion and its in vitro antitumor activity.
Karasulu HY; Karabulut B; Göker E; Güneri T; Gabor F
Drug Deliv; 2007 Apr; 14(4):225-33. PubMed ID: 17497355
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release.
Li Y; Kwon GS
Pharm Res; 2000 May; 17(5):607-11. PubMed ID: 10888314
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-conjugated and hyperbranched polyglycerol-grafted Fe₃O₄ magnetic nanoparticles for targeted anticancer effects.
Li M; Neoh KG; Wang R; Zong BY; Tan JY; Kang ET
Eur J Pharm Sci; 2013 Jan; 48(1-2):111-20. PubMed ID: 23108167
[TBL] [Abstract][Full Text] [Related]
20. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
